Clinical Trials
29 trialsOxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
Ain Shams University
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Damanhour University
Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
Damanhour University
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
National Cancer Institute (NCI)
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
National Cancer Institute (NCI)
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
National Cancer Institute (NCI)
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
National Cancer Institute (NCI)
Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
National Cancer Institute (NCI)
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
National Cancer Institute (NCI)
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
National Cancer Institute (NCI)
Genetics of Women With Lobular Carcinoma in Situ of the Breast
National Cancer Institute (NCI)
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
National Cancer Institute (NCI)
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
National Cancer Institute (NCI)
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
National Cancer Institute (NCI)
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
National Cancer Institute (NCI)
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
National Cancer Institute (NCI)
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
National Cancer Institute (NCI)